Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SymbioMatch is a Danish biotechnology company and Aarhus University spin-out that develops customized biofertilisers to enhance legume crop yields. The company utilizes an AI-driven platform to analyze complex tripartite interactions between soil, plants, and bacteria, identifying the most effective natural nitrogen-fixing bacteria for specific environments. By providing tailored biostimulant formulations coated directly onto seeds, SymbioMatch aims to reduce reliance on chemical fertilizers and promote sustainable agricultural practices. The company is currently supported by the BioInnovation Institute and other leading agrifood accelerators, and it is already generating revenue through paid pilot programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SymbioMATCH.